End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
59,900 KRW | +0.17% | +2.04% | -16.81% |
05-03 | SK Bioscience's Attributable Loss Narrows in Q1 | MT |
03-28 | SK Bioscience Signs Deal with Sanofi for Five Vaccine Types | MT |
ETFs positioned on SK bioscience Co.,Ltd.
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.57% | 2 M€ | -14.14% | ||
0.78% | 0 M€ | -4.02% | ||
0.04% | 0 M€ | +14.50% | ||
0.02% | 0 M€ | +8.81% | - | |
0.02% | 0 M€ | +8.01% | - | |
0.02% | 0 M€ | +5.91% | - | |
0.02% | 4 M€ | -4.41% | - | |
0.01% | 0 M€ | +3.95% | - | |
0.01% | 0 M€ | +4.81% | - | |
0.00% | 0 M€ | +8.24% | - | |
0.00% | 0 M€ | +5.79% | - | |
0.00% | 0 M€ | +5.63% | - | |
0.00% | 0 M€ | +3.63% | - | |
0.00% | 7 M€ | +0.11% | - |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-16.81% | 3.36B | |
-2.61% | 89.08B | |
+3.55% | 40.9B | |
-14.40% | 32.25B | |
+55.89% | 25.14B | |
-15.96% | 15.39B | |
-15.50% | 11.91B | |
-41.29% | 11.89B | |
-11.75% | 11.64B | |
+7.87% | 9.03B |
- Stock Market
- Equities
- A302440 Stock
- Funds and ETFs SK bioscience Co.,Ltd.